Metralindole

Summary

Metralindole (Inkazan) is a reversible inhibitor of monoamine oxidase A (RIMA) which was investigated in Russia as a potential antidepressant.[1] It is structurally and pharmacologically related to pirlindole.

Metralindole
Clinical data
Routes of
administration
Oral
ATC code
  • none
Legal status
Legal status
  • In general: ℞ (Prescription only)
Identifiers
  • 2,4,5,6-tetrahydro-9-methoxy-4-methyl-1H-3,4,6a-triazafluoranthene
CAS Number
  • 54188-38-4
  • HCl: 53734-79-5 checkY
PubChem CID
  • 68713
ChemSpider
  • 61964
UNII
  • 2QW3FL6OPA
  • HCl: M15TM76Y3L checkY
CompTox Dashboard (EPA)
  • DTXSID0045705 Edit this at Wikidata
Chemical and physical data
FormulaC15H17N3O
Molar mass255.321 g·mol−1
3D model (JSmol)
  • Interactive image
  • CN1CCN2C3=C(C=C(C=C3)OC)C4=C2C1=NCC4

See also edit

References edit

  1. ^ Andreeva NI, Golovina SM, Faermark MF, Shvarts GI, Mashkovskiĭ MD (1991). "[The comparative influence of pyrazidol, inkazan and other antidepressant monoamine oxidase inhibitors on the pressor effect of tyramine]". Farmakologiia I Toksikologiia (in Russian). 54 (2): 38–40. PMID 1884793.